U.S. Markets are not yet open, but GSK is being traded in the pre-market session. Pre-Market quote »
|40.51|| -0.45 / -1.10%|
GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare. The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare business markets a range of consumer health products based on scientific innovation. The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
|Andrew Philip Witty||Chief Executive Officer & Executive Director|
|Simon Dingemans||Chief Financial Officer & Executive Director|
|Nick Hirons||Senior VP-Global Ethics & Compliance Officer|
|Zhi Hong||Senior Vice President|
|Daniel E. Troy||Senior Vice President & General Counsel|